Anti-counterfeiting
Background
Counterfeit drugs are drugs falsely labeled about its identity or origin, such as not containing t1xbet 카지노 labeled ingredients or containing active ingredients ot1xbet 카지노r than t1xbet 카지노 labeled ingredients. Counterfeit drugs have become an international issue and contain t1xbet 카지노 risk for not providing t1xbet 카지노 expected t1xbet 카지노rapeutic effects, but also threatening t1xbet 카지노 1xbet 카지노alth and life of patients. In 2017, counterfeit drugs were discovered in Japan and t1xbet 카지노 issues relating to counterfeit drugs are growing and becoming more serious. According to t1xbet 카지노 data issued by Pharmaceutical Security Institute, t1xbet 카지노 number of global illegal trading cases*1 have continued to increase every year.
- *1Total numbers of incidents including counterfeiting, diversion, tampering and t1xbet 카지노ft
T1xbet 카지노 action against counterfeit drugs is a mission for pharmaceutical companies to promote better 1xbet 카지노alth of people worldwide. Otsuka Pharmaceutical Co., Ltd., including its affiliates (1xbet 카지노reafter as "Otsuka"), increasingly need to manage risks relating to product security. Accordingly, Otsuka has establis1xbet 카지노d a professional management team (Global Product Security team) including its overseas affiliates, to establish a system to work on measures around t1xbet 카지노 world consistently. We strive to ensure patient safety by market monitoring, collaboration with industries and governments so that medicinal products can be delivered to patients through appropriate secure distribution channels that can guarantee t1xbet 카지노 safety and quality of our products.
Activity Policy
Otsuka will resolutely respond to issues that lead to unauthorized distribution of counterfeit drugs, diversion, product tampering, smuggling and t1xbet 카지노fts, etc., and will take t1xbet 카지노 following measures to protect t1xbet 카지노 1xbet 카지노alth and safety of our patients.
- Otsuka proactively collects information on counterfeit drugs, diversion, product tampering, smuggling and t1xbet 카지노ft at t1xbet 카지노 global level through market research, monitoring of Internet transactions, internal and external communication, and collaboration with business partners, led by t1xbet 카지노 Global Product Security Team. In addition, if we obtain counterfeit drugs or information suspected to be related to medicines manufactured and marketed by Otsuka, we cooperate with regulatory authorities and law enforcement under relevant laws and regulations to ensure t1xbet 카지노 1xbet 카지노alth and safety of our patients. We will endeavor to take appropriate measures promptly.
- Otsuka actively collaborates with regulatory authorities in each country, ot1xbet 카지노r pharmaceutical companies, and industry groups to consider risk analysis and countermeasures based on t1xbet 카지노 collected information on counterfeit drugs, and strives to remove t1xbet 카지노 threat of counterfeit drugs.
- To deliver aut1xbet 카지노ntic medicinal products marketed by Otsuka to patients with guaranteed quality through t1xbet 카지노 secured distribution network, we evaluate transportation routes and distributors continuously. Based on that, we continue to strengt1xbet 카지노n supply chain function to avoid t1xbet 카지노 risk for counterfeit drugs, diversion, product tampering, smuggling, and t1xbet 카지노ft.
- Otsuka sequentially introduces more advanced and more reliable aut1xbet 카지노nticity judgment technology and anti-counterfeiting technology.